首页> 外国专利> AAV/UPR-plus virus, UPR-plus fusion protein, genetic treatment method and its use in the treatment of neurodegenerative diseases, such as Parkinson's disease and Huntington's disease, among others

AAV/UPR-plus virus, UPR-plus fusion protein, genetic treatment method and its use in the treatment of neurodegenerative diseases, such as Parkinson's disease and Huntington's disease, among others

机译：AAV / UPR-Plus病毒，UPR-Plus融合蛋白，遗传处理方法及其在治疗神经退行性疾病的治疗中，如帕金森病和亨廷顿的疾病等

页面导航

摘要
著录项
相似文献

摘要

The present invention presents a sequence of the AAV/UPR-plus virus, a genetic treatment method and its use in the treatment of neurodegenerative diseases, such as Parkinson's and Huntington's diseases, among others, as presented in the in vitro studies shown in FIG. 14/17.

机译：本发明呈现了AAV / UPR-Plus病毒的序列，遗传处理方法及其在治疗神经变性疾病的治疗中，例如帕金森和亨廷顿的疾病，其中如图2所示的体外研究所示。 14/17。

著录项

公开/公告号US2021079424A1

专利类型
公开/公告日2021-03-18

原文格式PDF
申请/专利权人 UNIVERSIDAD DE CHILE;
展开▼

申请/专利号US202017109018
发明设计人 CLAUDIO HETZ FLORES;RENE VIDAL GOMEZ;
展开▼

申请日2020-12-01
分类号C12N15/86;A61P25/28;C07K14/47;
国家 US
入库时间 2022-08-24 17:46:56

相似文献

专利
外文文献
中文文献